Author Archives: Shelly Rae Rich, PhD

Alport Syndrome Improved by Pentraxin-2 in Animal Model Study

Scientists have found that a recombinant human protein, pentraxin-2 (rhPTX-2), slows progression of kidney disease in mice with Alport syndrome, extends lifespan by 20% and reduces blood markers indicating kidney failure. These findings suggest a potential alternative therapy for chronic fibrotic kidney disease. Prior research has suggested…

Create your own user feedback survey